277 related articles for article (PubMed ID: 9695675)
1. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
4. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
5. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Takanashi M; Kadono Y; Tabata Y; Hibi S
Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
[TBL] [Abstract][Full Text] [Related]
8. [Transformation of aplastic anemia to acute myeloid leukemia with myelofibrosis following treatment with granulocyte colony-stimulating factor and erythropoietin].
Tsurumi H; Yamada T; Hara T; Murakami N; Moriwaki H; Muto Y
Rinsho Ketsueki; 1996 Jul; 37(7):630-2. PubMed ID: 8779784
[TBL] [Abstract][Full Text] [Related]
9. [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia].
Yamato H; Yamada K; Koike T; Yoshida M; Tsunogake S; Aoyagi M; Nakamura Y; Watanabe K; Saito K; Enokihara H
Rinsho Ketsueki; 1995 Feb; 36(2):128-33. PubMed ID: 7536277
[TBL] [Abstract][Full Text] [Related]
10. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
11. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
12. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
14. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
15. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
16. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Ohara A; Kojima S; Hamajima N; Tsuchida M; Imashuku S; Ohta S; Sasaki H; Okamura J; Sugita K; Kigasawa H; Kiriyama Y; Akatsuka J; Tsukimoto I
Blood; 1997 Aug; 90(3):1009-13. PubMed ID: 9242530
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of bicytopenia and pancytopenia during pregnancy].
Zhang C; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):488-91. PubMed ID: 19957545
[TBL] [Abstract][Full Text] [Related]
20. Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.
Bessho M; Hotta T; Ohyashiki K; Takahashi T; Mizoguchi H; Asano S; Ikeda Y; Sakurai M; Tojo A; Kizaki M; Iwanaga M; Tomonaga M; Hirashima K
Int J Hematol; 2003 Feb; 77(2):152-8. PubMed ID: 12627850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]